N-Acetylaspartate pp 77-93
Canavan Disease: Studies on the Knockout Mouse
- Cite this paper as:
- Matalon R., Michals-Matalon K., Surendran S., Tyring S.K. (2006) Canavan Disease: Studies on the Knockout Mouse. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., Namboodiri A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA
Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.
Unable to display preview. Download preview PDF.